vimarsana.com

Page 311 - Initiated Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

StockNews com Initiates Coverage on Capri (NYSE:CPRI)

StockNews.com began coverage on shares of Capri (NYSE:CPRI – Get Free Report) in a research report issued to clients and investors on Friday. The brokerage set a “hold” rating on the stock. Separately, Telsey Advisory Group reissued a “market perform” rating and issued a $57.00 price target on shares of Capri in a report on […]

Ashford (NYSEAMERICAN:AINC) Now Covered by StockNews com

Equities researchers at StockNews.com started coverage on shares of Ashford (NYSEAMERICAN:AINC – Get Free Report) in a note issued to investors on Friday. The brokerage set a “buy” rating on the financial services provider’s stock. Separately, Oppenheimer reduced their target price on Ashford from $17.00 to $14.00 and set an “outperform” rating for the company […]

Leju (NYSE:LEJU) Receives New Coverage from Analysts at StockNews com

Equities research analysts at StockNews.com started coverage on shares of Leju (NYSE:LEJU – Get Free Report) in a research note issued on Friday. The firm set a “buy” rating on the financial services provider’s stock. Leju Price Performance NYSE:LEJU opened at $1.24 on Friday. Leju has a one year low of $0.85 and a one […]

Soleno Therapeutics (NASDAQ:SLNO) Earns Overweight Rating from Analysts at Piper Sandler

Piper Sandler began coverage on shares of Soleno Therapeutics (NASDAQ:SLNO – Free Report) in a research note released on Monday morning, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $93.00 target price on the stock. A number of other equities analysts also recently weighed in on SLNO. Guggenheim reissued a buy rating […]

Jefferies Financial Group Initiates Coverage on Cabaletta Bio (NASDAQ:CABA)

Jefferies Financial Group assumed coverage on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a research report report published on Monday morning, MarketBeat reports. The firm issued a buy rating and a $36.00 price target on the stock. A number of other research firms have also commented on CABA. William Blair reiterated an outperform […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.